In addition, it addresses the FDA’s communications Using the applicant, the retention of data that help the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may well transfer possession of an SE report to a fresh applicant and Digital submission with the SE report and amendments.An